InspireMD Cash Conversion Cycle from 2010 to 2024

NSPR Stock  USD 3.00  0.02  0.67%   
InspireMD Cash Conversion Cycle yearly trend continues to be relatively stable with very little volatility. Cash Conversion Cycle is likely to drop to 218.13. During the period from 2010 to 2024, InspireMD Cash Conversion Cycle destribution of quarterly values had range of 243 from its regression line and mean deviation of  70.37. View All Fundamentals
 
Cash Conversion Cycle  
First Reported
2010-12-31
Previous Quarter
241.08727229
Current Value
218.13
Quarterly Volatility
82.22296423
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check InspireMD financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among InspireMD's main balance sheet or income statement drivers, such as Interest Expense of 23.9 K, Selling General Administrative of 8 M or Other Operating Expenses of 16.1 M, as well as many indicators such as Price To Sales Ratio of 10.44, Dividend Yield of 0.0 or PTB Ratio of 1.81. InspireMD financial statements analysis is a perfect complement when working with InspireMD Valuation or Volatility modules.
  
Check out the analysis of InspireMD Correlation against competitors.
To learn how to invest in InspireMD Stock, please use our How to Invest in InspireMD guide.

Latest InspireMD's Cash Conversion Cycle Growth Pattern

Below is the plot of the Cash Conversion Cycle of InspireMD over the last few years. It is InspireMD's Cash Conversion Cycle historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in InspireMD's overall financial position and show how it may be relating to other accounts over time.
Cash Conversion Cycle10 Years Trend
Pretty Stable
   Cash Conversion Cycle   
       Timeline  

InspireMD Cash Conversion Cycle Regression Statistics

Arithmetic Mean196.70
Geometric Mean180.59
Coefficient Of Variation41.80
Mean Deviation70.37
Median168.07
Standard Deviation82.22
Sample Variance6,761
Range243
R-Value(0.17)
Mean Square Error7,072
R-Squared0.03
Significance0.55
Slope(3.11)
Total Sum of Squares94,649

InspireMD Cash Conversion Cycle History

2024 218.13
2023 241.09
2022 174.63
2021 137.18
2020 317.96
2019 168.07
2018 111.83

About InspireMD Financial Statements

InspireMD shareholders use historical fundamental indicators, such as Cash Conversion Cycle, to determine how well the company is positioned to perform in the future. Although InspireMD investors may analyze each financial statement separately, they are all interrelated. The changes in InspireMD's assets and liabilities, for example, are also reflected in the revenues and expenses on on InspireMD's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Cash Conversion Cycle 241.09  218.13 

Pair Trading with InspireMD

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if InspireMD position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in InspireMD will appreciate offsetting losses from the drop in the long position's value.

Moving together with InspireMD Stock

  0.64EW Edwards Lifesciences CorpPairCorr
  0.69GH Guardant HealthPairCorr

Moving against InspireMD Stock

  0.63ENSG Ensign GroupPairCorr
  0.62DRIO DarioHealth CorpPairCorr
  0.6EDAP EDAP TMS SAPairCorr
  0.49VTAK Catheter PrecisionPairCorr
  0.49EKSO Ekso Bionics HoldingsPairCorr
The ability to find closely correlated positions to InspireMD could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace InspireMD when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back InspireMD - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling InspireMD to buy it.
The correlation of InspireMD is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as InspireMD moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if InspireMD moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for InspireMD can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Additional Tools for InspireMD Stock Analysis

When running InspireMD's price analysis, check to measure InspireMD's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy InspireMD is operating at the current time. Most of InspireMD's value examination focuses on studying past and present price action to predict the probability of InspireMD's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move InspireMD's price. Additionally, you may evaluate how the addition of InspireMD to your portfolios can decrease your overall portfolio volatility.